Palo Alto Investors LP Athenex, Inc. Transaction History

Palo Alto Investors LP

  • $727 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$1.36 - $2.94 $432,752 - $935,508
-318,200 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$11.06 - $14.01 $679,084 - $860,214
61,400 Added 23.91%
318,200 $3.52 Million
Q3 2020

Nov 16, 2020
BUY
$10.26 - $14.55 $734,616 - $1.04 Million
71,600 Added 38.66%
256,800 $3.11 Million
Q2 2020

Aug 14, 2020
BUY
$7.11 - $13.76 $1.32 Million - $2.55 Million
185,200 New
185,200 $2.55 Million

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Palo Alto Investors LP Portfolio

Follow Palo Alto Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email